What can we help you find?

Leading the way in transplantation

Filter results for:

ESOT TLJ 3.0: Setting the Stage for a Rigorous, Regularly Updated Development Process

NEWLY PUBLISHED: ๐—˜๐—ฆ๐—ข๐—ง ๐—–๐—ผ๐—ป๐˜€๐—ฒ๐—ป๐˜€๐˜‚๐˜€ ๐—ฃ๐—น๐—ฎ๐˜๐—ณ๐—ผ๐—ฟ๐—บ ๐—ณ๐—ผ๐—ฟ ๐—ข๐—ฟ๐—ด๐—ฎ๐—ป ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—ฝ๐—น๐—ฎ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป: ๐—ฆ๐—ฒ๐˜๐˜๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—ฆ๐˜๐—ฎ๐—ด๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—ฎ ๐—ฅ๐—ถ๐—ด๐—ผ๐—ฟ๐—ผ๐˜‚๐˜€, ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐—ฟ๐—น๐˜† ๐—จ๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ๐—ฑ ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ ๐—ฃ๐—ฟ๐—ผ๐—ฐ๐—ฒ๐˜€๐˜€

About ELITA

The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe. To provide a forum for those working in the field of liver and intestinal transplantation to exchange scientific information and views

About EF CLIF

The European Foundation for the Study of Chronic Liver Failure (EF CLIF) is a private non-profit organization connecting biomedical researchers and healthcare professionals with each other, with patients and patient associations, and with society. The fundamental purpose of EF CLIF, reflected in its founding Statements of 2015, is to advance knowledge and promote research and

The European Medicines Agency (EMA) announcements

ESOT would like to share two recent transplant-related announcements made by the EMA.   EMA consultation: iBox Scoring System in kidney transplant patients The EMA has published for public consultation a โ€œdraft qualification opinion for the iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patientsโ€.

ETAHP Call for Nominations

The European Transplant Allied Healthcare Professionals (ETAHP) – would like to announce a call for nominations for two new Board members. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. You may nominate yourself or a colleague. The new ETAHP Board Members will hold office for 4 years (2022-2026), starting December 2022. In

Info Session on the ESOT Mentorship Programme!

Do you want to learn more on the ESOT Mentorship Programme before applying either as mentors or mentees? Do you have any doubts on this new opportunity for professional development? Join us at the Info Session on Tuesday 18 October at 18:30 CEST! Luca Toti, Chair of the Education Committee, and Liset Pengel, Vice-Chair, will

CareDxโ€™s AlloSeq cfDNA Represents a Minimally Invasive, Accurate Method to Detect Graft Injury as a Leading Solution for Transplant Patient Management in Europe

CareDx has developed AlloSeq cfDNA, a targeted NGS assay that relies on 202 single-nucleotide polymorphisms (SNPs) located throughout the genome to measure the dd-cfDNA in transplant recipients. The assay was designed to be fully compatible with any clinical laboratory setup and combines a streamlined workflow with a fully automated analysis software to accurately quantify dd-cfDNA in transplant recipients.

Menu